23% of RA patients have moderate-to-severe Obstructive Sleep Apnea (AHI ≥ 15) - study of RA patients 199 patients underwent PSG, OSA is more common in RA than in the general population, but there is no relationship with disease activity. https://t.co/wNasW3AerN

• https://bit.ly/2WWP1LN

Surveys/interviews w/ 1010 patients suggest Telehealth worked best for routine & familiar health issues w/ pre-existing clinical relationship. Telehealth less suitable when examination was needed, when Dx was unknown, when patients prefered F2F visis https://t.co/QZYBzxyGz6

• https://bit.ly/3oolOoQ

Risk of venous thromboembolism is increased in ankylosing spondylitis patients. Study of 7190 pt shows a 2 fold risk, higher in the first year - risks for PE (HR 2.88), DVT (HR 2.20) and VTE overall (HR 2.10 ) were increased. https://t.co/TIhlKuRw8S

• https://bit.ly/3pL6L95

#Bestof2020 Update on Polymyalgia Rheumatica and Giant Cell Arteritis https://t.co/8Kxts1X43H https://t.co/j06SFRxQ3m

• https://bit.ly/2Lm4CBL

NEJM: Actemra Studied in COVID pneumonia and shown to improve outcomes (mech ventilation or death ;12 vs 19.3%) but did not improve survival (10.4 vs 8.6%). 389 hospitalized pts randomized 2:1 to get 2 IV doses Actemra +SOC vs SOC alone https://t.co/BdslXFXOYD

• https://bit.ly/3rKDRYJ

MIRROR OL study shows that when pegloticase is co-administered with methotrexate, a high rate of response is seen (79% or 11/14 pts), achieved a complete response (sUA < 6 mg/dL) at Month 6. Topline results announced by Horizon. https://t.co/DNIt5zs8xA

• https://bit.ly/34YS9Ls

Analysis of worldwide data on Abatacept shows that compared with other bDMARDs, ABA was not associated with an increased overall cancer risk [ROR 0.98 (95% CI 0.91, 1.05)], but may be increased for risk of melanoma [1.58 (95% CI 1.17, 2.08)] https://t.co/8IQRHoPqBl

• https://bit.ly/3n4aZXQ

23% of RA patients have moderate-to-severe Obstructive Sleep Apnea (AHI ≥ 15) - study of RA patients 199 patients underwent PSG, OSA is more common in RA than in the general population, but there is no relationship with disease activity. https://t.co/wNasW3AerN

• https://bit.ly/2WWP1LN

Great read from early last year-Physicians estimate that about 15% of their patients - they dread to see; as they cause aversion, fear, despair or even malice. Washington post reviews how demanding patients should and should not be with their physicians. https://t.co/etCclBXFNu

• https://bit.ly/350j61f

Plasmapheresis Indications : TTP, HUS, Cryoglobulinemia, Hyperviscosity, Myasthenia gravis, Goodpastures, Catastrophic APL Syn, Chr inflamm demyelinating polyneuropathy, Removal of drugs/toxins, Alveolar hemorrhage, ANCA vasculitis (questionable) https://t.co/8TBExIx0Kx

• https://bit.ly/34XZo6p

ENTRACTE trial studied the risk of major adverse CV events (MACE) in 3080 RA pts Rx with tocilizumab (TCZ) vs etanercept (ETN), and found no increased risk of MACE in TCZ patients compared to ETN (HR 1.05 (95% confidence interval 0.77–1.43). https://t.co/KpOEeVAAxx

• https://bit.ly/3pw0NZM

ACR Fireside Chats - Spondyloarthritis Abstracts ACR 2020 Fireside Chats - featuring Drs. Laura Coates and Alexis Ogdie. Abstract discussions on nr-axSpA, AS and axial PsA https://t.co/r5Cf4WS63s

• https://bit.ly/2X5gOcI

#Bestof2020 New EULAR/ACR Classification Criteria for SLE https://t.co/FWpDmIf6gc https://t.co/MSeNojAEIN

• https://bit.ly/3o0kBE1